Patent acquisition screening: value, availability and fit
Screen patents to buy or license by keeping value, availability and fit apart, then check title, maintenance, terminal disclaimers and encumbrances.
By the One Transform team5 min read
Screening patents to buy or license works best when three questions stay separate: how valuable the patent is, whether it is available, and whether it fits what you need. Each question draws on different evidence and carries a different level of certainty. Folding them into one score tends to hide the fact that most often decides a deal: whether the owner will actually sell or license.
Question 1: value
Value is what the patent could do for whoever holds it, regardless of who that is today.
- Claim scope. Read the independent claims. Fewer and broader limitations reach more products, but check the prosecution history for narrowing statements and note how easily a product could design around each claim.
- Remaining term. Work out the actual expiry, including adjustment, terminal disclaimers and fee status (how to work out a US patent's expiry). A strong claim with two years left is worth much less than one with twelve, unless the buyer is mainly after past damages.
- Family and jurisdiction coverage. Pending continuations can produce new claims aimed at current products, and foreign counterparts extend coverage to other markets. Patent families: continuations, divisionals and CIPs covers how to map them.
- Evidence of use. Products that appear to practice the claims, charted limitation by limitation with sources. Without that evidence, value is a forecast.
- Validity exposure. Strong prior art, earlier petitions at the PTAB and possible § 112 problems all reduce what the patent is worth. If the patent has been challenged, read what its PTAB history tells you.
Question 2: availability
Availability asks who owns the patent and whether they would sell or license it on terms you can accept. Public records tell you who the recorded owner is. They do not tell you what that owner wants, so every availability signal is an inference, not a fact.
Owner type is the usual starting point:
| Owner | Common position | Signals worth checking |
|---|---|---|
| Operating company | Often holds patents to protect its own products; a sale in a core area is less likely, a license outside its field more likely | Has it left the product line? Has it sold or licensed patents before? |
| University | Usually licenses through a technology transfer office; may already have exclusive licensees | Published licensing opportunities, existing licensees |
| Individual inventor | Decisions depend on personal circumstances; sale or license is often possible | Fee payment history, prior assignments |
| Licensing entity | Licensing is the business; a sale is sometimes possible at a price | Licensing and litigation history |
Other signals help. An owner that stopped paying maintenance fees on related patents may be pruning the portfolio. A recent merger or restructuring can change what the owner considers core. Record each signal as a reason to test in conversation, not as a conclusion.
Question 3: fit
Fit asks whether the patent covers what you need, and that depends on the goal you set before screening starts.
- Your own products. For a defensive purchase, the claims usually read on what you sell, so that nobody else can acquire the patent and assert it against you.
- A competitor's products. For licensing or negotiating position, the claims should map onto products a competitor sells now, in the markets where the patent is in force. A competitor portfolio analysis helps define which products those are.
- A standard. If the claims track a specification the market must implement, check whether existing standards commitments already apply to the patent.
The same patent can be an excellent fit for one buyer and irrelevant to another. Fit is always measured against a stated goal.
Why one number misleads
A common shortcut is to score each patent on the three questions and combine them. Here is a hypothetical with a weighted average:
| Patent A | Patent B | |
|---|---|---|
| Value (0–10) | 10 | 7 |
| Fit (0–10) | 9 | 8 |
| Availability (0–10) | 1 | 9 |
| Weighted score (value 50%, fit 30%, availability 20%) | 7.9 | 7.7 |
Patent A ranks first. It is also owned by a company that builds its main product line on it and has never sold a patent, so the 7.9 describes an asset nobody can buy. Patent B is slightly weaker on paper and held by an owner that has licensed before.
A weighted average lets a strength on one axis buy back a decisive weakness on another. Two practices avoid that. First, rank on value and fit, and treat availability as a separate column or a filter applied before outreach. Second, keep the reasons attached to each axis, so a reviewer can see that A's availability rests on an inference worth testing, not on a fact.
Diligence before you commit
Screening produces a shortlist. Before signing, check what the public record and the seller can confirm.
- Chain of title. Trace ownership from every inventor to the current owner through the USPTO's recorded assignments, including mergers and name changes. Under 35 U.S.C. § 261, an assignment must be recorded at the USPTO within three months, or before a later purchase, to be effective against a later purchaser for value without notice. Gaps are common and usually fixable, but fix them before closing.
- Maintenance status. Confirm that every fee due under 35 U.S.C. § 41(b) has been paid. A lapsed patent can be reinstated on petition under 37 C.F.R. § 1.378 if the delay was unintentional, but that petition should be filed and decided before closing.
- Terminal disclaimers. Under 37 C.F.R. § 1.321, a terminally disclaimed patent expires no later than its reference patent. A disclaimer filed to overcome double patenting also states that the patent is enforceable only while it is commonly owned with the reference patent. Buying one family member without the other can leave you holding a patent you cannot enforce.
- PTAB history. List pending petitions, instituted trials and final written decisions, and note who is estopped from which grounds.
- Encumbrances the USPTO record does not show. Existing licenses, covenants not to sue, standards commitments and settlement terms from past disputes are usually not recorded. Buyers generally assume these survive the sale, so they ask the seller to list them and to stand behind the list in the agreement.
Where One Transform fits
One Transform's Acquisition Targets search, one of its nine search types, ranks patents and portfolios by fit to a goal you define, weighing commercial value, technical relevance and strategic position. The output is a scored shortlist with the reasoning attached, and each finding links to its sources.
For candidates that make the shortlist, a Validity search scores each claim on a 0–10 scale with the references and reasoning behind it, and a Similar Patents search finds the closest alternatives if the first choice turns out to be unavailable. Whether the owner will deal is still a question for a conversation with the owner.
Next step
Write down the goal, run an Acquisition Targets search at onetransform.ai, and take the shortlist through the diligence list above.
This article is general information about patent practice, not legal advice. For advice on a specific matter, consult a registered patent attorney or agent.
